Idexx Laboratories (IDXX) Equity Ratio (2009 - 2026)

Idexx Laboratories (IDXX) has reported Equity Ratio for 18 consecutive years, with 0.46 the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Ratio rose 2.01% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (up 2.01% YoY), while the FY2025 annual figure was 0.48, down 1.09% from the prior year.
• Equity Ratio came in at 0.46 for Q1 2026 at Idexx Laboratories, down from 0.48 in the prior quarter.
• The five-year high for Equity Ratio was 0.48 in Q4 2024, with the low at 0.18 in Q2 2022.
• Average Equity Ratio over 5 years is 0.39, with a median of 0.45 recorded in 2025.
• Across the five-year window, Equity Ratio plunged 43.49% in 2022 and soared 133.15% in 2023, its largest moves.
• Year by year, Equity Ratio stood at 0.22 in 2022, then soared by 105.48% to 0.46 in 2023, then advanced by 6.37% to 0.48 in 2024, then dropped by 1.09% to 0.48 in 2025, then slipped by 4.06% to 0.46 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.46, 0.48, and 0.46 for Q1 2026, Q4 2025, and Q3 2025 respectively.